Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07402226

Systemic Sclerosis DIet for GastrointESTinal Symptoms

SSc-DIGEST Trial: Systemic Sclerosis DIet for GastrointESTinal Symptoms Randomized Controlled Trial of Low FODMAP, CDED, and NICE Diets for Gastrointestinal Symptoms in Systemic Sclerosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.

Detailed description

The rationale for keeping the diets (arms/interventions names) vague is it prevents other researchers from using these diets in their studies, minimizes expectation bias of patients (who can have preference for one diet over other) and prevents participants from trying other diets before end of study period in case they don't respond.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDiet 1: Restriction of fermentable carbohydrates6 weeks guided diet under the supervision of a dietician restricting fermentable carbohydrates known to trigger GI symptoms.
BEHAVIORALDiet 2: Elimination of foods harmful to gut barrier and microbiome6 weeks guided diet under the supervision of a dietician eliminating of foods harmful to gut barrier and microbiome
BEHAVIORALDiet 3: Regular meal patterns, soluble fiber, and portion control6 weeks guided diet under the supervision of a dietician emphasizing regular meal patterns, soluble fiber, and portion control.

Timeline

Start date
2026-03-16
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2026-02-11
Last updated
2026-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07402226. Inclusion in this directory is not an endorsement.